Spelling suggestions: "subject:"renin"" "subject:"benin""
81 |
The pancreatic renin-angiotensin system: its roles in pancreatic islets and in type 2 diabetes. / CUHK electronic theses & dissertations collectionJanuary 2008 (has links)
In the first study, I aimed to compare the angiotensin II type 1 receptor (AT1R) expression levels of the isolated pancreatic islets from normal and mouse model of T2DM. In addition, 4-week-old diabetic mice were orally treated with AT1R antagonist losartan for 8 weeks. It is found that AT1R mRNA was upregulated markedly in diabetic islets and double-immunolabeling confirmed that AT1R was localized to beta-cells. Losartan selectively improved glucose-induced insulin release and (pro)insulin biosynthesis in diabetic islets. Oral losartan treatment delayed the onset of diabetes, and reduced hyperglycemia and glucose intolerance in diabetic mice. These data indicate that AT1R antagonism improves beta-cell function and glucose tolerance in young T2DM mice. / In the second study, I aimed to examine how the upregulated RAS could impair beta-cell function, where oxidative stress is the potential mediator. Meanwhile, T2DM results in oxidative stress-mediated activation of uncoupling protein 2 (UCP2), a negative regulator of islet function. Thus, it was postulated that some of the protective effects of AT1R antagonism might be mediated through interference with this pathway and tested this hypothesis in a mouse model of T2DM. In order to achieve this, losartan was given to 4-week-old diabetic mice for 8 weeks. UCP2-driven oxidative damage and apoptosis were analyzed in isolated islets. Results showed that losartan selectively inhibited oxidative stress via NADPH oxidase downregulation; this in turn suppressed UCP2 expression, thus improving beta-cell insulin secretion while decreasing apoptosis-induced beta-cell mass loss in diabetic mice islets. These data indicate that islet AT1R activation in young diabetic mice can lead to progressive islet beta-cell failure through UCP2-driven oxidative damage and apoptosis. / The mechanisms by which chronic hyperglycemia associated with glucotoxicity causes beta-cell dysfunction and apoptosis remain ambiguous. Voltage-gated outward potassium (Kv) current, which mediates beta-cell membrane potential and limits insulin secretion, could play a role in glucotoxicity. Meanwhile the RAS has been shown to be upregulated by prolonged exposure to high glucose. In the third part of my study, I therefore investigated the effects of prolonged exposure to high glucose and angiotensin II (Ang II) on the expression and activity of Kv channels in mouse pancreatic beta-cell. Dissociated mice beta-cells, incubated in 5.6 mM or 28 mM glucose for 3-5 days, were used for electrophysiological study; while isolated islets cultured for 1-7 days were proceeded for gene/protein expression analysis. Both Kv channel expression and current were markedly increased by prolonged glucose incubation. Simultaneously, Ang II reduced Kv current under normal glucose condition, while high glucose incubation abolished the effect of Ang II. Moreover, the ability of Ang II on Kv current reduction was eliminated by inhibiting AT2R but not AT1R. These data indicated that Ang II reduced Kv current via AT2R, which was abolished by prolonged high glucose incubation. On the other hand, high glucose increased Kv channel expression and current, which might alter the ability of insulin secretion in beta-cell. (Abstract shortened by UMI.) / Chu, Kwan Yi. / Adviser: P. S. Leung. / Source: Dissertation Abstracts International, Volume: 70-06, Section: B, page: 3246. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 163-188). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.
|
82 |
Urinary gene expression as a marker of glomerular podocyte injury and disturbance of renin-angiotensin system in patients with diabetic nephropathy. / CUHK electronic theses & dissertations collectionJanuary 2008 (has links)
Diabetic nephropathy (DN) is one of the leading causes of end stage renal disease (ESRD) in western world and has a trend to spread in developing countries. Pathogenesis of DN is not fully elucidated. Studies of recent years showed that podocyte loss and activation of the rennin-angiotensin system (RAS), especially intra-renal RAS, played important roles in this process. Although renal biopsy is currently the most common way used to determine the expression pattern of podocyte and RAS associated molecules in DN, this invasive procedure has its own risk and is not practical for serial monitoring. We hypothesized that measurement of messenger ribonucleic acid (mRNA) expression of related genes in the urinary sediment might be a useful way to assess the severity of DN. / Firstly, we found that urinary mRNA expressions of podocyte-associated molecules nephrin, podocin, synaptopodin, Wilm's tumor-1 (WT-1) and alpha-actinin-4 were higher in patients with DN than in healthy controls, and urinary nephrin, podocin and synaptopodin expression was related to proteinuria and baseline renal function. In addition, there was a close relationship between urinary mRNA expression of type 2 angiotensin converting enzyme (ACE2), a key element of RAS, and the degrees of proteinuria, renal function and rate of decline of glomerular filtration rate (GFR). Urinary mRNA expression of ACE also inversely correlated with the rate of renal function decline. / In the next step, we studied the change in urinary mRNA expression of nephrin, podocin, synaptopodin, ACE and ACE2 in patients with DN treated with angiotensin converting enzyme inhibitor (ACEI) and addition of angiotensin receptor blocker (ARB). We found that urinary mRNA expression of podocin, synaptopodin and propably nephrin increased with disease progression, and percentage change in urinary podocin expression negatively correlated with rate of decline of GFR. Furthermore, serial measurement of urinary expression of nephrin and possibly synaptopodin may reflect therapeutic response to ARB in these patients. Urinary mRNA expression of ACE and ACE2, however, remained unchanged during the study duration and did not correlate with therapeutic response. / In this series of work, we investigated (i) the relation between the gene expression profile of podocyte-associated molecules and RAS related molecules in the urinary sediment and the severity of DN, including clinically defined parameter of disease severity, histological scarring, and the degree of intra-renal podocyte loss, (ii) the relation between urinary and intra-renal gene expression of patients with DN, (iii) the application of urinary gene expression on the monitoring of disease progression and therapy response of DN. The urinary mRNA expression of related genes was quantified by real-time quantitative polymerase chain reaction (RT Q-PCR). The intra-renal mRNA expression of related genes was studied from the histologic specimens of kidney biopsy by laser catapult microdissection (LCM) and RT Q-PCR. The degree of renal scarring was determined by morphometric analysis. Glomerular podocyte number was determined by stereological study on serial sections of renal biopsy specimen. / Taken together, our results suggest that although urinary mRNA expression of podocyte and RAS associated molecules is not related to intra-renal expression, urinary expression has the potential to be used as a non-invasive tool to assess the severity and progression of DN, and serial measurements of urinary gene expression of podocyte associated molecules may be used to reflect therapy response for patients with DN. Our findings also indicate that the information from urinary gene expression is supplementary to, but not a surrogate of, the data obtained from renal biopsy. / We then examined the relation between urinary gene expression and histological changes in the kidney. We found that urinary WT-1 expression correlated with the degree of kidney fibrosis. Unlike intra-renal expression, urinary mRNA expression of podocyte associated molecules did not correlate with glomerular podocyte number. There was also no association between urinary and intra-renal mRNA expression. / Wang, Gang. / Adviser: Cheuk Chen Szeto. / Source: Dissertation Abstracts International, Volume: 70-06, Section: B, page: 3423. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 156-180). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.
|
83 |
Einfluss des Renin-Angiotensin-Systems auf die menschliche Erythropoetinproduktion unter normoxischen Bedingungen und nach Stimulation durch Fenoterol / Influence of the renin-angiotensin-system on the humen erythopoietin production under normoxic conditions and after stimulation by fenoterolSchenck, Tim 09 November 2010 (has links)
No description available.
|
84 |
Experimentální a klinické aspekty nefrotoxicity kalcineurinových inhibitorů / Experimental and clinical aspect of calcineurin inhibitors-induced nephrotoxicity.Hošková, Lenka January 2018 (has links)
The introduction of calcineurin inhibitors (CNI) into immunosuppressive regimens significantly improved patients prognosis after heart transplantation. Some of the most significant complications have been recognized, such as the development of arterial hypertension and renal impairment due to calcineurin inhibitor toxicity. The aim of the study was to compare the effect of the dual blockade of the renin-angiotensin system (dual RAS combination) with standard antihypertensive medication on blood pressure control. The second aim was to evaluate whether effective antihypertensive combination therapy (dual RAS or a standard antihypertensive drugs combination) would reduce the progression of chronic kidney disease in patients with chronic immunosuppressive prophylaxis. Treatment of arterial hypertension involving the combination of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin II receptor blocker (ARB) was similarly effective compared to the standard combination of antihypertensives. Blood pressure treatment targets were achieved in both studies. Administration of antihypertensive combination therapy including dual blockade of RAS alleviated the progression of chronic renal disease in the experimental and clinical part, where the nephroprotective effect of dual RAS blockade...
|
85 |
Remodelace levé komory srdeční u pacientů s primárním hyperaldosteronismem a esenciální hypertenzí / Left ventricle remodeling in patients with primary aldosteronism and essential hypertensionIndra, Tomáš January 2016 (has links)
Myocardial damage is one of the most serious consequences of arterial hypertension. Changes in the heart structure and function develop not only due to pressure overload itself, but many other hemodynamic and neurohumoral factors contribute to their formation. Our work has compared echocardiohraphic strucutural anf functional changes of the left ventricle, caused by essential hypertension and hypertension associated with primary aldosteronism (PA) as the most common reason for secondary hypertension. The first part of our work focused on the differences in left ventricle geometry in men with PA and essential hypertension after separating it's low-renin form (where, similarly to PA, the plasma volume expansion was considered to have the dominant effect on left ventricle remodelation). In men with low-renin forms of hypertension including PA, we observed greater both endsystolic and enddiastolic diameter of the left ventricle, lower relative wall thickness and more frequent eccentric type of hypertrophy when compared to essential hypertensives with normal renin levels. Whereas left ventricle cavity diameters were positively correlated to aldosterone levels, wall thicknesses were associated mainly with hypertension severity expressed as an average 24hour blood pressure and number of antihypertensives....
|
86 |
Caracterização de um sistema renina-angiotensina local no tecido gengival de rato / Characterization of a local renin-angiotensin system in the rat gingival tissueAna Eliza Akashi 28 March 2008 (has links)
O sistema renina-angiotensina (SRA) circulante é um sistema endócrino que promove a produção de angiotensina (Ang) II, a qual exerce seus efeitos pela interação com receptores específicos. O conceito clássico do SRA circulante está sendo modificado, pois tem sido demonstrada a existência de sistemas locais capazes de gerar angiotensinas de forma independente do SRA circulante em vários tecidos e órgãos. Trabalhos recentes sugerem a existência de alguns componentes do SRA em tecido gengival e fibroblastos gengivais de diferentes espécies. Porém, não são encontrados na literatura achados inequívocos sobre a presença de importantes componentes do SRA, tais como renina e angiotensinogênio, no tecido gengival de rato. Portanto, os objetivos do presente trabalho foram: 1) estudar a expressão e localização de componentes do SRA no tecido gengival de rato e 2) estudar in vitro a funcionalidade do SRA local em homogenato de tecido gengival de rato quanto à formação de Ang II e outros peptídeos vasoativos a partir de precursores de Ang II. Transcrição reversa seguida de reação em cadeia da polimerase (RTPCR) foi utilizada para avaliar a expressão de RNAm. Análise imunohistoquímica foi utilizada para detecção e localização de renina no tecido gengival de rato. Um método fluorimétrico padronizado com o tripeptídeo Hipuril-Histidina-Leucina (Hip-His-Leu) foi usado para medir a atividade da ECA em homogenatos de tecido gengival de rato. A técnica de cromatografia líqüida de alto desempenho (HPLC) foi usada para analisar os produtos formados após a incubação de homogenatos de tecido gengival de rato com Ang I ou tetradecapeptídeo substrato de renina (TDP). RT-PCR revelou a expressão de RNAm para renina, angiotensinogênio, ECA e receptores de Ang II (AT1a, AT1b e AT2) em tecido gengival; em fibroblastos cultivados de tecido gengival foi observada expressão de RNAm para renina, angiotensinogênio e receptor AT1a. A técnica de imunohistoquímica demonstrou a existência de renina em vasos de tecido gengival de rato. Atividade da ECA foi detectada por meio do ensaio fluorimétrico (4,95±0,89 nmol His-Leu/g.min). Quando Ang I foi usada como substrato, análises de HPLC mostraram a formação de Ang 1-9 (0,576±0,128 nmol/mg.min), Ang II (0,066±0,008 nmol/mg.min) e Ang 1-7 (0,111±0,017 nmol/mg.min), enquanto que os mesmos peptídeos (0,139±0,031; 0,206±0,046 e 0,039±0,007 nmol/mg.min, respectivamente) e Ang I (0,973±0,139 nmol/mg.min) foram formados quando TDP foi usado como substrato. Adicionalmente, análises de HPLC revelaram a ausência de enzimas que degradam Ang II em homogenatos de tecido gengival de rato. Em conclusão, os resultados apresentados neste trabalho mostram claramente a existência de um SRA local em tecido gengival de rato, que é capaz de gerar Ang II e outros peptídeos vasoativos in vitro. Estudos adicionais são necessários para elucidar o papel deste sistema local no tecido gengival de rato. / Systemic renin-angiotensin system (RAS) promotes the plasmatic production of angiotensin (Ang) II, which acts through the interaction with specific receptors. The concept of this classic circulating RAS has been modified since there is growing evidence that local systems in various tissues and organs are capable of generating angiotensins independently of the circulating RAS. Recent works suggest the existence of some RAS components in the gingival tissue and cultured gingival fibroblasts of different species, but there is paucity of data in the literature regarding the unequivocal existence of crucial RAS components, such as renin and angiotensinogen, in the rat gingival tissue. Therefore, the aims of the present work were to: 1) study the expression and localization of RAS components in the rat gingival tissue and 2) evaluate the in vitro production of Ang II and other peptides catalyzed by rat gingival tissue homogenates incubated with different precursors of Ang II. Reverse transcription-polymerase chain reaction (RT-PCR) was used to assess mRNA expression. Immunohistochemical (IHC) analysis aimed to detect and localize renin in the rat gingival tissue. A standardized fluorimetric method with the tripeptide Hippuryl-Histidyl-Leucine (Hip-His-Leu) was used to measure tissue ACE activity in rat gingival tissue homogenates. High performance liquid chromatography (HLPC) was used to analyze the products formed after the incubation of rat gingival tissue homogenates with Ang I or tetradecapeptide renin substrate (TDP). RT-PCR revealed the mRNA expression for renin, angiotensinogen, ACE and Ang II receptors (AT1a, AT1b and AT2) in the rat gingival tissue; cultured gingival fibroblasts expressed renin, angiotensinogen and AT1a receptor. IHC demonstrated the existence of renin in vessels of the rat gingival tissue. ACE activity was detected by the fluorimetric assay (4.95±0.89 nmol His-Leu/g.min). When Ang I was used as the substrate, HPLC analyses showed the formation of Ang 1-9 (0.576±0.128 nmol/mg.min), Ang II (0.066±0.008 nmol/mg.min) and Ang 1-7 (0.111±0.017 nmol/mg.min) whereas these same peptides (0.139±0.031; 0.206±0.046 and 0.039±0.007 nmol/mg.min, respectively) and Ang I (0.973±0.139 nmol/mg.min) were formed when TDP was the substrate. Additionally, HPLC revealed absence of Ang II degrading enzymes in rat gingival tissue homogenates. In conclusion, the results presented here clearly show the existence of a local RAS in the rat gingival tissue, which is capable of generating Ang II and other vasoactive peptides in vitro. Further studies are required to elucidate the role of this system in the rat gingival tissue.
|
87 |
Úloha Rho-kinázové signální dráhy v regulaci krevního tlaku u normotenzních a hypertenzních potkanů / The role of Rho-kinase signaling pathway in the regulation of blood pressureBrunová, Aneta January 2015 (has links)
Calcium sensitization represents a mechanism that enables vascular smooth muscle cells to change the sensitivity of the contractile apparatus to intracellular calcium The aim of this study was to determine to what extent is calcium sensitization modulated by the renin- angiotensin system (RAS), sympathetic nervous system (SNS), nitric oxide (NO) and prostanoids produced by cyclooxygenase (COX). For this purpose we studied the effects of acute and chronic blockade of particular systems on blood pressure changes elicited in conscious normotensive rats by administration of Rho-kinase inhibitor fasudil. Adult male chronically cannulated Wistar rats were used in all experiments. Main findings of this study are as follow: 1) Decrease of blood pressure elicited by Rho-kinase inhibition was enhanced under the conditions of acute NOS inhibition. Inhibition of NOS was shown to have a bigger effect than COX inhibition (this was confirmed under the conditions of acute RAS and SNS inhibition as well). These findings are in agreement with the hypothesis that NO exerts a suppressive effect on calcium sensitization. 2) Chronic NOS inhibition caused hypertension characterized by a more pronounced blood pressure lowering after Rho-kinase inhibition in comparison with control. NO chronically suppresses the calcium...
|
88 |
Vliv kombinované blokády endotelinového a renin-angiotenzinového systému na krevní tlak a regresi chronického onemocnění ledvin u modelu angiotensin II - dependentní formy hypertenze / Effect of combined endothelin and renin-angiotensin systems blockade on blood pressure and chronic kidney disease regression in model of angiotensin II-dependent hypertensionSedláková, Lenka January 2017 (has links)
and key words Enhanced activation of renin-angiotensin system (RAS) and endothelin system (ES) plays the key pathophysiological role in the progression of hypertension and the chronic kidney disease (CKD). The aim of this study was to verify wheter the combined inhibition RAS and selective inhibition ETA receptor for endothelin 1 (ET-1) will show additive renoprotective effects in experimental model CKD. This therapeutic aproach was tested on the transgenic rats with mouse renin gen (TGR), to whome ablation nephrectomy (5/6 NX) was done in the age of 6 weeks. After next 6 weeks the relevant treatment was given in drinking-water: dual RAS blockade (trandolapril 6mg/L + losartan 100mg/L) or the combination of dual RAS blockade + inhibitor of ETA receptor (atrasentan 25mg/L). Results of the first series show 100 % mortality in untreated rats with 5/6 NX to the 30th week. Both type of treatments increased the survival rate up to 30 % in 5/6 NX TGR after the 50th week. In the second series influence of treatments on the blood pressure (BP) was monitored in 5/6 NX TGR, which had systolic BP over 210 mmHg. Both treatments decreased BP to the level normotensive rats and reduced heart hypertrophy. In the third series the results showed that treatment significantly decreased renal level of angiotensin II...
|
89 |
Remodelace levé komory srdeční u pacientů s primárním hyperaldosteronismem a esenciální hypertenzí / Left ventricle remodeling in patients with primary aldosteronism and essential hypertensionIndra, Tomáš January 2016 (has links)
Myocardial damage is one of the most serious consequences of arterial hypertension. Changes in the heart structure and function develop not only due to pressure overload itself, but many other hemodynamic and neurohumoral factors contribute to their formation. Our work has compared echocardiohraphic strucutural anf functional changes of the left ventricle, caused by essential hypertension and hypertension associated with primary aldosteronism (PA) as the most common reason for secondary hypertension. The first part of our work focused on the differences in left ventricle geometry in men with PA and essential hypertension after separating it's low-renin form (where, similarly to PA, the plasma volume expansion was considered to have the dominant effect on left ventricle remodelation). In men with low-renin forms of hypertension including PA, we observed greater both endsystolic and enddiastolic diameter of the left ventricle, lower relative wall thickness and more frequent eccentric type of hypertrophy when compared to essential hypertensives with normal renin levels. Whereas left ventricle cavity diameters were positively correlated to aldosterone levels, wall thicknesses were associated mainly with hypertension severity expressed as an average 24hour blood pressure and number of antihypertensives....
|
90 |
[en] EFFECTS OF ANTIHYPERTENSIVES ON ANXIETY-LIKE BEHAVIORS IN ANIMAL MODELS / [pt] USO DE ANTI-HIPERTENSIVOS NA MODULAÇÃO DA ANSIEDADE EM MODELOS ANIMAIS09 June 2021 (has links)
[pt] Os transtornos de ansiedade afetam milhares de pessoas em todo o mundo, sendo representados como um dos principais distúrbios mentais. A ansiedade é acompanhada por uma série de respostas comportamentais e fisiológicas, quando na presença de estímulos aversivos. Essas respostas provocam ações neuroendócrinas envolvendo o sistema nervoso simpático (SNS), o eixo hipotálamo-pituitária-adrenal (HPA) e o sistema renina-angiotensina (SRA). Pesquisas feitas em modelos animais possibilitam uma melhor compreensão dos mecanismos neurofisiológicos e comportamentais associados à patologias observadas em humanos. Os animais Cariocas com Alto Congelamento (CAC) e Cariocas com Baixo Congelamento (CBC) são duas linhagens condicionadas de ratos que apresentam, respectivamente, níveis altos ou baixos de respostas semelhantes à ansiedade. O presente estudo investigou os efeitos da Losartana e Valsartana, sendo ambas da classe antagonistas do receptor de angiotensina II, na modulação da ansiedade nos ratos CAC, CBC e ratos controle. O tratamento crônico com Losartana e o tratamento agudo com Valsartana não produziram efeitos significativos nas respostas comportamentais associadas à ansiedade no condicionamento de medo contextual, campo aberto e labirinto em cruz elevado. Nossos dados sugerem que nas doses e duração dos tratamentos, a administração destes medicamentos anti-hipertensivos não é capaz de modular a ansiedade nos animais CAC e CBC. / [en] Anxiety disorders affect thousands of people all around the world, being represented as the most common of mental disorders. Anxiety is associated with a number of behavioral and physiological responses when faced with aversive stimuli. These responses provoke neuroendocrine actions involving the activation of the sympathetic nervous system (SNS), the hypothalamic-pituitary-adrenal axis (HPA) and the renin-angiotensin system (RAS). Studies on animal models allow for a better understanding of the neurophysiological and behavioral mechanisms associated with pathologies observed in humans. The Carioca High Freezing (CHF) and Carioca Low Freezing (CLF) are two conditioned strains of rats that present, respectively, high or low levels of anxiety-like responses. The present study investigated the effects of Losartan and Valsartan, both angiotensin II receptor blockers, on the modulation of anxiety-like behaviors of CHF, CLF and control rats. Neither chronic treatment of Losartan nor acute treatment of Valsartan yielded significant effects on anxiety measurements in the contextual fear conditioning, open field and elevated plus maze tests. Thus, our findings suggest that at the doses and durations of treatment tested, administration of these antihypertensive drugs did not play a modulating role of anxiety-like behaviors in CHF and CLF animals.
|
Page generated in 0.04 seconds